Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

PURPOSE: Adult post-transplantation lymphoproliferative disease (PTLD) has a reported 3-year overall survival (OS) of 35% to 40%. The impact of rituximab on the outcome of PTLD is not well defined. METHODS: We examined the clinical features and outcomes among a large cohort of solid organ transplant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Evens, Andrew M., David, Kevin A., Helenowski, Irene, Nelson, Beverly, Kaufman, Dixon, Kircher, Sheetal M., Gimelfarb, Alla, Hattersley, Elise, Mauro, Lauren A., Jovanovic, Borko, Chadburn, Amy, Stiff, Patrick, Winter, Jane N., Mehta, Jayesh, Van Besien, Koen, Gregory, Stephanie, Gordon, Leo I., Shammo, Jamile M., Smith, Scott E., Smith, Sonali M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834429/
https://ncbi.nlm.nih.gov/pubmed/20085936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4961
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados